PDC*line Pharma
Biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine
PDC*line Pharma has raised €26M across 2 funding rounds from 9 investors, most recently a round in Jan 2024. Based in Liege, Belgium; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€26M
€25,600,000
Funding rounds
2
Investors
9
distinct backers
Active since
2021-12
latest 2024-01
Funding by year
EUR raised per yearPDC*line Pharma — funding by year — interactive chart.
Data table
| PDC*line Pharma — funding by year | |
|---|---|
| 2021 | €18M |
| 2024 | €8.1M |
Signals
Medium confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Down/flat last round
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-01-18 | Other | €8.1M | — | View deal → |
| 2021-12-06 | Series B | €18M | Alpha Ventures,Brain Asset Management,Hansongneotech Co.,Korea Investment Partners,Noshaq,Sambrinvest+3 more | View deal → |
Investors
9Related news
- PDC*line Pharma Raises €17.5M in Series B2 Financing Roundfinsmes.com · 2021-12
- tech.eu
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData